Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal serum alpha-fetoprotein screening.

B K Burton1

  • 1Center for Medical and Reproductive Genetics, Michael Reese Hospital and Medical Center, Chicago, Illinois 60616.

Pediatric Annals
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Home visits in the Danish High Risk and Resilience Study - VIA 7: assessment of the home environment of 508 7-year-old children born to parents diagnosed with schizophrenia or bipolar disorder.

Acta psychiatrica Scandinavica·2019
Same author

Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizures.

Clinical genetics·2017
Same author

Inhibition of protein kinase C (PKC) response of voltage-gated calcium (Cav)2.2 channels expressed in Xenopus oocytes by Cavβ subunits.

Neuroscience·2014
Same author

The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study.

Journal of inherited metabolic disease·2007
Same author

Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene.

Neurology·2003
Same author

Urea cycle disorders.

Clinics in liver disease·2001

Maternal serum alpha-fetoprotein (MSAFP) screening is a valuable prenatal care tool. It efficiently screens for neural tube defects and offers insights into other pregnancy complications, benefiting maternal and infant health.

Area of Science:

  • Obstetrics and Gynecology
  • Prenatal Diagnostics
  • Biochemical Markers in Pregnancy

Background:

  • Maternal serum alpha-fetoprotein (MSAFP) screening is a standard component of prenatal care.
  • The utility of MSAFP screening has surpassed initial expectations in identifying potential fetal abnormalities.

Purpose of the Study:

  • To highlight the benefits and broad applicability of MSAFP screening in prenatal diagnostics.
  • To emphasize the evolving understanding of factors influencing MSAFP levels and future refinements.

Main Methods:

  • Routine offering of MSAFP screening to all pregnant patients.
  • Utilizing MSAFP levels as a screening tool for various pregnancy-related conditions.

Main Results:

Related Experiment Videos

  • MSAFP screening is an efficient and cost-effective method for detecting neural tube defects.
  • Provides crucial information for identifying other birth defects and pregnancy complications.

    • Conclusions:

    • MSAFP screening offers significant benefits for maternal and infant health.
    • Ongoing research into factors affecting MSAFP levels will lead to further improvements in screening accuracy and application.